What Is Delirious Mania? Symptoms, Causes, and Treatment

Delirious mania is a rare and potentially life-threatening neuropsychiatric emergency in which full-blown manic excitement, delirium with fluctuating consciousness, and features of catatonia collide in the same person at the same time.¹ The combination can look like several other conditions, which means it is frequently missed or treated incorrectly. When recognized early, though, specific treatments can resolve it rapidly, and understanding what sets it apart is the first step.

A Condition Without a Formal Home in Diagnostic Manuals

The syndrome was first described in 1849 by the physician Luther Bell, who documented a cluster of asylum patients with acute mania, disorientation, and high fevers that often ended in death. For much of the next century and a half, the condition went by several names: Bell’s mania, mania with delirium, and eventually delirious mania.² Despite that long history, no major international diagnostic manual, including the DSM or ICD, recognizes delirious mania as its own diagnosis. That gap matters. Without formal criteria, clinicians may not think to look for it, and patients can cycle through misdiagnoses for days before anyone considers the right treatment.

Estimates of how common the syndrome actually is have shifted over time. It was long thought to be exceedingly rare, but more recent reviews suggest it may account for up to about 15% of all acute mania cases.³ That figure is far higher than most clinicians expect, and it raises the possibility that many cases are simply being labeled as ordinary severe mania or delirium from another cause.

What the Symptoms Actually Look Like

The hallmark of delirious mania is the simultaneous presence of three symptom clusters that clinicians usually think of as separate problems. Understanding all three and how they overlap is key to recognizing the syndrome.

Manic excitement: The person is intensely agitated, with pressured or incoherent speech, grandiosity, sleeplessness, and extremely high energy. Unlike a typical manic episode, however, the patient is not oriented to where or when they are and cannot communicate in any organized way.
Delirium: Consciousness fluctuates. The person may swing from hyperarousal to a dazed, confused state within hours. They lose awareness of their surroundings, cannot track time, and may not recognize familiar people. This is the feature that distinguishes delirious mania from an ordinary severe manic episode.
Catatonic features: Alongside the agitation, signs of catatonia often appear. These can include waxy posturing, mutism, repetitive purposeless movements, negativism (rigid resistance to any instruction), or sudden shifts between extreme excitement and stupor.¹

On the physical side, fever is common and sometimes dangerously high. Autonomic instability, including rapid heart rate, wild blood pressure swings, and profuse sweating, often accompanies the psychiatric symptoms. Dehydration and exhaustion follow quickly because the person is too agitated to eat or drink and too confused to cooperate with care. If the syndrome is not treated, it can progress rapidly in severity and become life-threatening.³

Who Is Most Affected

Data on delirious mania come largely from case series rather than large epidemiological studies, so demographic patterns should be taken as suggestive rather than definitive. In one of the more detailed case reviews, which evaluated 16 patients, the median age at presentation was 21, with two outliers at ages 43 and 64. Roughly four out of five patients were women.⁴ That young, female-skewed profile is consistent with what other smaller case reports have described, though it is not clear whether the syndrome genuinely favors young women or whether older patients are more likely to have their symptoms attributed to another diagnosis.

A separate case report noted delirious mania appearing for the first time in an older adult, emphasizing that the syndrome is not limited to young people and can catch clinicians off guard when it presents outside the expected age range.² The takeaway is that age alone should not rule the diagnosis in or out.

Causes and Triggers

Most reported cases arise in people who already have bipolar disorder, and an episode of delirious mania may emerge during what initially appears to be a typical manic episode that escalates. But the syndrome is not exclusively a bipolar phenomenon. Several medical conditions can produce the same clinical picture, and part of the diagnostic workup is ruling out these secondary causes.

Anti-NMDA Receptor Encephalitis

One of the most important secondary causes to consider is anti-NMDA receptor encephalitis, an autoimmune condition in which the body produces antibodies against receptors in the brain. This form of encephalitis frequently presents with psychiatric symptoms first, including agitation, psychosis, and catatonia, and can closely mimic delirious mania. Research has found that delirious mania is actually a frequent neuropsychiatric presentation of anti-NMDA receptor encephalitis, and its appearance should prompt clinicians to test for the condition.⁵ A broader study of patients with neurological disorders confirmed the association between catatonic delirium and encephalitis, including both viral and anti-NMDA receptor types.⁶

This connection is clinically important because anti-NMDA receptor encephalitis requires immunotherapy, not the psychiatric treatments that work for primary delirious mania. Missing it means the patient gets the wrong treatment entirely.

Infections and Neuroinflammation

Viral infections beyond encephalitis can also trigger the syndrome. A case report during the COVID-19 pandemic described delirious mania developing in a patient with otherwise mild COVID-19 pneumonia, with neuroinflammation identified as a possible mechanism.⁷ That case illustrated how an infection outside the brain can still provoke severe neuropsychiatric symptoms through inflammatory pathways. Other infections, metabolic derangements, and toxic exposures have all been reported as triggers in the literature, which is why a thorough medical workup matters even when the psychiatric history seems to explain everything.

Why It Gets Confused with Other Conditions

The diagnostic confusion around delirious mania comes from the fact that its three main symptom clusters each point clinicians toward a different diagnosis. Delirium alone triggers a search for medical causes such as infection, metabolic problems, or medication toxicity. Mania alone triggers a mood disorder framework. Catatonia triggers its own differential, including schizophrenia and autoimmune conditions. When all three appear simultaneously, clinicians who focus on whichever symptom is most obvious may land on the wrong diagnosis.

Two conditions in particular cause the most confusion. The first is neuroleptic malignant syndrome, a dangerous reaction to antipsychotic medications that also produces fever, autonomic instability, altered consciousness, and muscle rigidity. The overlap with delirious mania is substantial, and in some cases clinicians have debated whether the two are even distinct entities or exist on a spectrum of “malignant catatonia.”⁸ Differentiating them matters in practice because the treatment approach is different: neuroleptic malignant syndrome requires stopping antipsychotics immediately, while delirious mania may sometimes benefit from certain atypical antipsychotics.

The second commonly confused condition is simple severe mania. A patient in the throes of a manic episode can look wildly agitated and disorganized, but if they remain oriented and do not have true clouding of consciousness or catatonic signs, the episode is better classified as severe mania rather than delirious mania. The distinction has treatment implications, because standard mania responds to mood stabilizers and antipsychotics while delirious mania often does not.

Treatment That Works and Treatment That Makes Things Worse

The treatment evidence for delirious mania, while based on case series rather than large randomized trials, points consistently in the same direction. Two interventions stand out as effective, and certain commonly used psychiatric medications can actually worsen the condition.

Electroconvulsive Therapy

Electroconvulsive therapy (ECT) produces the most consistent and dramatic improvement. In case reports, patients who had been critically ill for days showed resolution of delirium after just a couple of sessions, with full recovery by around the sixth session.⁸ Across all available case data, ECT has shown consistent and significant benefit, making it the closest thing the field has to a first-line treatment for this syndrome.⁴ The speed of response is striking compared with medications, which can take weeks to produce improvement when they work at all.

High-Dose Benzodiazepines

High-dose lorazepam is the other well-supported intervention. In many cases, aggressive benzodiazepine dosing helped control the acute agitation and catatonic features.³ This is consistent with the broader evidence that catatonia, regardless of its cause, tends to respond to benzodiazepines. In practice, many patients receive lorazepam first (because it can be started immediately) with ECT added if the response is inadequate.

What to Avoid

One of the most clinically dangerous aspects of delirious mania is that the medications clinicians would instinctively reach for in an acutely psychotic, agitated patient can make things worse. Typical (first-generation) antipsychotics such as haloperidol and anticholinergic drugs led to clinical worsening in reviewed cases.⁴ This is a critical practical point: haloperidol is one of the most commonly used emergency medications for acute agitation in psychiatric and emergency settings, and giving it to someone in delirious mania can deepen the crisis. Atypical antipsychotics, lithium, and valproate produced variable results and, when they did help, took an average of about three and a half weeks to show benefit. Clozapine showed some promise in a small number of cases but took about four weeks on average, making it impractical for the acute phase.

The implication is that standard psychiatric pharmacotherapy alone is often insufficient and sometimes harmful. Patients who are treated with the usual mania toolkit without ECT or high-dose benzodiazepines may deteriorate, require prolonged hospitalization, or develop new manic episodes.⁹

Recovery, Recurrence, and What Happens Afterward

With appropriate treatment, the prognosis for delirious mania is surprisingly good given how dire the acute presentation looks. Delirium tends to clear first, sometimes within days of starting ECT, unmasking the underlying manic symptoms, which then resolve more gradually over the following sessions or weeks. In one case report, both patients treated with ECT remained in remission on prophylactic lithium at the one-year follow-up.⁸

That pattern of delirium resolving faster than mania has been observed across multiple case series, though it is not universal.⁹ In practice, this means that a patient may emerge from the delirious phase and still require weeks of treatment for the residual manic episode. The hospital stay is longer than for a typical manic episode, and the recovery trajectory can be confusing for patients and families who see the most dramatic symptoms lift quickly and then wonder why their loved one still is not well.

Recurrence is another concern. In one case series, two out of five patients experienced a second episode of delirious mania, suggesting that once someone has had one episode, they remain at risk for future ones.⁹ That risk makes long-term mood stabilization after recovery especially important, though the optimal maintenance regimen has not been studied in any formal way.

The Role of Catatonia in Understanding Delirious Mania

If there is one thread that ties together the diagnosis, treatment, and misdiagnosis of delirious mania, it is catatonia. The syndrome’s responsiveness to benzodiazepines and ECT, its worsening with typical antipsychotics, and its overlap with neuroleptic malignant syndrome all make much more sense when you view delirious mania as fundamentally a form of catatonia rather than a subtype of mania. Catatonia itself is a motor and behavioral syndrome that can arise from many different causes, and its treatments (benzodiazepines, ECT) are distinct from the treatments for psychosis or mania.

Clinicians who screen for catatonic signs in any patient presenting with acute mania and confusion are far more likely to catch delirious mania early. The screening itself is straightforward, involving observation for posturing, waxy flexibility, mutism, echolalia, and stereotyped movements. Many of these signs can be spotted without any specialized testing. The problem is that catatonia screening is not routine in most emergency departments or even in many inpatient psychiatric units, partly because the older image of catatonia as a rare, immobile state does not match the excited, agitated form seen in delirious mania.

When to Suspect Anti-NMDA Receptor Encephalitis Instead

Given how closely anti-NMDA receptor encephalitis can mimic primary delirious mania, clinicians and families should be aware of certain red flags that push toward the autoimmune diagnosis. Young women are disproportionately affected by both conditions, so demographics alone do not help distinguish them. However, anti-NMDA receptor encephalitis is more likely when seizures develop, when the psychiatric symptoms were preceded by a viral-like illness, or when an ovarian teratoma (a specific type of tumor) is found on imaging. The presence of involuntary movements that look more like dyskinesias than classic catatonic postures also tips the balance toward encephalitis.

The key diagnostic step is testing cerebrospinal fluid for anti-NMDA receptor antibodies, which requires a lumbar puncture. Because this test takes time and the patient is critically ill, many treatment protocols call for starting empiric treatment for delirious mania (benzodiazepines and ECT) while awaiting results. If the antibody test comes back positive, immunotherapy such as steroids, intravenous immunoglobulin, or plasma exchange becomes the primary treatment.⁵ Missing this diagnosis means the underlying autoimmune process continues unchecked, with a high risk of relapse even if the acute psychiatric symptoms temporarily improve.

Practical Implications for Patients and Families

For someone watching a family member in delirious mania, the experience is terrifying. The person may be unrecognizable: screaming, confused, physically rigid or thrashing, running a fever, and utterly unable to communicate. Understanding a few practical realities can help families advocate during a crisis.

First, if the standard mania medications do not seem to be working after the first couple of days, or if the patient is getting worse on haloperidol or similar antipsychotics, families should ask the treatment team whether delirious mania has been considered and whether ECT is available. Many community hospitals do not have ECT capabilities, and transfer to a facility that does may be necessary. Second, a medical workup should happen alongside psychiatric treatment. Blood tests, brain imaging, and in some cases a lumbar puncture are needed to rule out infections, autoimmune encephalitis, and metabolic causes. Third, the recovery period is longer than families expect. Even after the delirium clears, weeks of inpatient treatment for residual mania are common, and mood stabilization medications will need to be established before discharge.

Because the syndrome has no formal diagnostic code in the DSM or ICD, insurance authorization for ECT or prolonged hospitalization can sometimes be a challenge. Clinicians typically document the condition under the broader categories of bipolar disorder with psychotic features or catatonia, and families should be prepared for the possibility that the name “delirious mania” may not appear anywhere in the official medical record even when it is the working clinical diagnosis.

1
PubMed Central. The crossroad of delirium, mania, and catatonia: A case series on delirious mania
2
PubMed. Late-onset delirious mania: Does it ring a bell?
3
Journal of Psychiatric Practice. Delirious mania: Detection, diagnosis, and clinical management in the acute setting
4
PubMed. Delirious mania: clinical features and treatment response
5
PubMed. Delirious mania as a frequent and recognizable neuropsychiatric syndrome in patients with anti-NMDAR encephalitis
6
PubMed. Clinical Significance of Delirium With Catatonic Signs in Patients With Neurological Disorders
7
BMJ Case Reports. Delirious mania in a patient with COVID-19 pneumonia
8
PubMed. Electroconvulsive therapy in the treatment of delirious mania: a report of 2 patients
9
PubMed Central. Clinical features of delirious mania: a series of five cases and a brief literature review